WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
Reproducibility benchmarks: Because AOD-9604 has been extensively characterized, it is frequently used as a positive control in new lipolysis assay development
Discussing B12 Shots & Injections: Highlighting Concerns Surrounding Cyanocobalamin unhealthy Potential Negative Health Effects
For NNMT assays remember that the compound competes at the nicotinamide substrate site, so the apparent potency depends on the nicotinamide concentration used
Copper ions are also suggested to exhibit antioxidant properties
With its focus on lean muscle retention, efficient fat burning, and workout compatibility, AOD9604 is designed to support individuals seeking a transformative and sustainable weight loss experience